Fighting Enteroviral Infections to Prevent ...
Document type :
Article dans une revue scientifique: Article original
PMID :
Permalink :
Title :
Fighting Enteroviral Infections to Prevent Type 1 Diabetes.
Author(s) :
Nekoua, Magloire Pandoua [Auteur]
Laboratoire de virologie - ULR 3610
Mercier, Ambroise [Auteur]
Laboratoire de Virologie - ULR 3610 [Laboratoire de Virologie]
Alhazmi, Abdulaziz [Auteur]
Laboratoire de Virologie - ULR 3610 [Laboratoire de Virologie]
Sane, Famara [Auteur]
Laboratoire de virologie - ULR 3610
Alidjinou, Enagnon Kazali [Auteur]
Laboratoire de virologie - ULR 3610
Hober, Didier [Auteur]
Laboratoire de virologie - ULR 3610
Laboratoire de virologie - ULR 3610
Mercier, Ambroise [Auteur]
Laboratoire de Virologie - ULR 3610 [Laboratoire de Virologie]
Alhazmi, Abdulaziz [Auteur]
Laboratoire de Virologie - ULR 3610 [Laboratoire de Virologie]
Sane, Famara [Auteur]
Laboratoire de virologie - ULR 3610
Alidjinou, Enagnon Kazali [Auteur]
Laboratoire de virologie - ULR 3610
Hober, Didier [Auteur]
Laboratoire de virologie - ULR 3610
Journal title :
Microorganisms
Abbreviated title :
Microorganisms
Volume number :
10
Pages :
768
Publication date :
2022-04-26
ISSN :
2076-2607
English keyword(s) :
enteroviruses
coxsackievirus
antiviral
vaccine
type 1 diabetes
coxsackievirus
antiviral
vaccine
type 1 diabetes
HAL domain(s) :
Sciences du Vivant [q-bio]/Immunologie/Vaccinologie
English abstract : [en]
Enteroviruses (EVs), especially coxsackieviruses B (CVB), are believed to trigger or accelerate islet autoimmunity in genetically susceptible individuals that results in type 1 diabetes (T1D). Therefore, strategies are ...
Show more >Enteroviruses (EVs), especially coxsackieviruses B (CVB), are believed to trigger or accelerate islet autoimmunity in genetically susceptible individuals that results in type 1 diabetes (T1D). Therefore, strategies are needed to fight against EV infections. There are no approved antiviral drugs currently available, but various antiviral drugs targeting viral or host cell proteins and vaccines have recently shown potential to combat CVB infections and may be used as new therapeutic strategies to prevent or reduce the risk of T1D and/or preserve β-cell function among patients with islet autoantibodies or T1D.Show less >
Show more >Enteroviruses (EVs), especially coxsackieviruses B (CVB), are believed to trigger or accelerate islet autoimmunity in genetically susceptible individuals that results in type 1 diabetes (T1D). Therefore, strategies are needed to fight against EV infections. There are no approved antiviral drugs currently available, but various antiviral drugs targeting viral or host cell proteins and vaccines have recently shown potential to combat CVB infections and may be used as new therapeutic strategies to prevent or reduce the risk of T1D and/or preserve β-cell function among patients with islet autoantibodies or T1D.Show less >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
Université de Lille
CHU Lille
CHU Lille
Collections :
Submission date :
2024-01-17T22:08:49Z
2024-02-13T09:07:25Z
2024-02-13T09:07:25Z
Files
- microorganisms-10-00768-v2.pdf
- Non spécifié
- Open access
- Access the document